Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) have received a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $50.00.

A number of equities research analysts recently commented on SLP shares. KeyCorp lifted their price objective on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 16th. StockNews.com lowered Simulations Plus from a "hold" rating to a "sell" rating in a report on Monday, April 14th. Finally, William Blair reiterated an "outperform" rating on shares of Simulations Plus in a research note on Wednesday, January 8th.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the sale, the director now directly owns 3,402,584 shares in the company, valued at $115,381,623.44. The trade was a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 19.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Simulations Plus

A number of hedge funds have recently bought and sold shares of SLP. Barclays PLC increased its position in shares of Simulations Plus by 390.6% in the third quarter. Barclays PLC now owns 28,473 shares of the technology company's stock worth $911,000 after purchasing an additional 22,669 shares during the period. Proficio Capital Partners LLC acquired a new position in shares of Simulations Plus during the fourth quarter worth $719,000. Geode Capital Management LLC lifted its holdings in Simulations Plus by 4.4% during the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company's stock worth $14,367,000 after buying an additional 18,924 shares during the period. State Street Corp grew its position in shares of Simulations Plus by 4.7% in the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company's stock valued at $20,503,000 after buying an additional 28,953 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Simulations Plus by 106.0% in the third quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company's stock valued at $1,517,000 after buying an additional 24,371 shares during the period. 78.08% of the stock is owned by institutional investors.

Simulations Plus Stock Up 3.7 %

SLP stock traded up $1.21 during midday trading on Thursday, reaching $33.90. 472,415 shares of the company's stock traded hands, compared to its average volume of 194,961. The company has a 50-day simple moving average of $28.51 and a two-hundred day simple moving average of $30.11. Simulations Plus has a 1-year low of $23.01 and a 1-year high of $51.22. The company has a market cap of $681.76 million, a price-to-earnings ratio of 84.75 and a beta of 1.13.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.06. The firm had revenue of $22.43 million for the quarter, compared to the consensus estimate of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The business's revenue for the quarter was up 22.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.20 EPS. Equities research analysts forecast that Simulations Plus will post 1.09 EPS for the current year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.